The FDA on Tuesday announced it is establishing a new advisory committee that will discuss and evaluate potential treatments for genetic metabolic diseases which disrupt the body’s metabolism.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,